Stem cell therapy for Autism Spectrum Disorder — for patients from Netherlands

If you are researching Autism Spectrum Disorder treatment from the Netherlands, the obstacle is usually access or cost: standard options have plateaued, and regenerative therapy at home runs to €14,600–€46,000. Stem Plus offers the same European GMP standard for a fraction of that — and an easy, mostly visa-free trip.

How Autism Spectrum Disorder is treated

Autism Spectrum Disorder stems from alterations in neuronal connectivity and immune signalling during neurodevelopment. Stem-cell research explores whether mesenchymal stem cells derived from placental tissue or amniotic membrane can modulate neuroinflammation, support synaptic plasticity, and promote neural integration. These cells are selected because they secrete immunoregulatory factors and can differentiate into supportive glial cells. Neurogenic cells are also being studied to repair damaged neural circuits, while exosomes — extracellular vesicles released by stem cells — are examined as vehicles for delivering anti-inflammatory signals to the brain. Current approaches remain investigational; the evidence base comprises preclinical work and early clinical trials. No mechanism yet explains why or how stem cells would alter the core neurobiological features of autism in humans. It is delivered under a physician-led protocol and designed to complement your existing care.

Your cost from Netherlands

Cost ranges are indicative market figures for planning, not quotes.